| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |